ASIA: +91 96043 17127 | USA: 1 (347) 690-0211 | Translate : 

Covid-19

AI in Drug Discovery Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

report img

AI in Drug Discovery Market by Drug Type (Small Molecule and Large Molecule), By Technology ((Machine Learning (Deep Learning, Supervised Learning, Reinforcement Learning, Unsupervised Learning) and Others)), By Therapeutic Area (Metabolic Diseases, Cardiovascular Diseases, Immuno-Oncology, Oncology, Neurodegenerative Diseases, Others), By End User (Pharmaceutical Companies, Biopharmaceutical Companies, Academic & Research Institutes, and Others): Global and Regional Industry Perspective, Comprehensive Analysis, and Forecasts, 2021–2026

Industry Insights

[221+ Pages Report] According to Facts and Factors, the global AI for Drug Discovery Market was valued at about USD 360.01 million in 2020, and is predicted to create revenue of about USD 2,596.6 million by the end of 2026, rising at a CAGR of roughly 39% between 2021 and 2026.

The report covers the forecast and analysis of the AI for the drug discovery market on a global and regional level. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to 2027 based on revenue (USD Million). The study includes drivers and restraints of the AI for the drug discovery market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the AI for drug discovery market on a global level.

In order to give the users of this report a comprehensive view of the AI for drug discovery market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides a company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the AI for the drug discovery market by segmenting the market based on the drug type, technology, therapeutic area, end-user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2027. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East, and Africa.

With giant pharma firms focusing on genetic data interpretation of patients, the market for AI for drug discovery is likely to gain traction over the forecast timeline. Understanding the patient’s genetic profile assists in providing apt medicines as well as a medical treatment for the patients. Moreover, the computational approaches of machine learning help in analyzing the genetic data of the patient and propose new drugs and therapies.

Based on drug type, the market is sectored into small molecules and large molecules.  On the basis of technology, the industry is classified into deep learning, machine learning, and others. In terms of therapeutic area, the market is divided into metabolic diseases, immuno-oncology, neurodegenerative diseases, cardiovascular diseases, oncology, and others. Based on the end-user, the market is segmented into pharmaceutical companies, academic & research institutes, biopharmaceutical companies, and others.

logoGlobal AI for Drug Discovery Market: By Drug Type Segment Analysis
• Small Molecule
• Large Molecule

logoGlobal AI for Drug Discovery Market: By Technology Segment Analysis
• Deep Learning
• Machine Learning
• Others

logoGlobal AI for Drug Discovery Market: By Therapeutic Area Segment Analysis
• Metabolic Diseases
• Immuno-Oncology
• Neurodegenerative Diseases
• Cardiovascular Diseases
• Oncology
• Others

logoGlobal AI for Drug Discovery Market: By End User Segment Analysis
• Pharmaceutical Companies
• Academic & Research Institutes
• Biopharmaceutical Companies
• Others
 

logoGlobal AI for Drug Discovery Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

 

Table of Content

  1. Chapter 1 Executive Summary
    1. 1.1. Introduction of AI for Drug Discovery
    2. 1.2. Global AI for Drug Discovery Market, 2020 & 2026 (USD Million)
    3. 1.3. Global AI for Drug Discovery Market, 2016 – 2026 (USD Million)
    4. 1.4. Global AI for Drug Discovery Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
    5. 1.5. Global AI for Drug Discovery Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
    6. 1.6. COVID-19 Impacts on AI for Drug Discovery Market
      1. 1.6.1. COVID-19 Impact on the Players
      2. 1.6.2. Business Strategies and Recommendations
  2. Chapter 2 AI for Drug Discovery Market – Drug Type Analysis
    1. 2.1. Global AI for Drug Discovery Market – Drug Type Overview
    2. 2.2. Global AI for Drug Discovery Market Share, by Drug Type, 2020 & 2026 (USD Million)
    3. 2.3. Small Molecule
      1. 2.3.1. Global Small Molecule AI for Drug Discovery Market, 2016 – 2026 (USD Million)
    4. 2.4. Large Molecule
      1. 2.4.1. Global Large Molecule AI for Drug Discovery Market, 2016 – 2026 (USD Million)
  3. Chapter 3 AI for Drug Discovery Market – Technology Analysis
    1. 3.1. Global AI for Drug Discovery Market – Technology Overview
    2. 3.2. Global AI for Drug Discovery Market Share, by Technology, 2020 & 2026 (USD Million)
    3. 3.3. Machine Learning
      1. 3.3.1. Global Machine Learning AI for Drug Discovery Market, 2016 – 2026 (USD Million)
    4. 3.4. Others Technologies
      1. 3.4.1. Global Others Technologies AI for Drug Discovery Market, 2016 – 2026 (USD Million)
  4. Chapter 4 AI for Drug Discovery Market – Therapeutic Area Analysis
    1. 4.1. Global AI for Drug Discovery Market – Therapeutic Area Overview
    2. 4.2. Global AI for Drug Discovery Market Share, by Therapeutic Area, 2020 & 2026 (USD Million)
    3. 4.3. Metabolic Diseases
      1. 4.3.1. Global Metabolic Diseases AI for Drug Discovery Market, 2016 – 2026 (USD Million)
    4. 4.4. Cardiovascular Diseases
      1. 4.4.1. Global Cardiovascular Diseases AI for Drug Discovery Market, 2016 – 2026 (USD Million)
    5. 4.5. Immuno-Oncology
      1. 4.5.1. Global Immuno-Oncology AI for Drug Discovery Market, 2016 – 2026 (USD Million)
    6. 4.6. Oncology
      1. 4.6.1. Global Oncology AI for Drug Discovery Market, 2016 – 2026 (USD Million)
    7. 4.7. Neurodegenerative Diseases
      1. 4.7.1. Global Neurodegenerative Diseases AI for Drug Discovery Market, 2016 – 2026 (USD Million)
    8. 4.8. Others
      1. 4.8.1. Global Others AI for Drug Discovery Market, 2016 – 2026 (USD Million)
  5. Chapter 5 AI for Drug Discovery Market – End User Analysis
    1. 5.1. Global AI for Drug Discovery Market – End User Overview
    2. 5.2. Global AI for Drug Discovery Market Share, by End User, 2020 & 2026 (USD Million)
    3. 5.3. Pharmaceutical Companies
      1. 5.3.1. Global Pharmaceutical Companies AI for Drug Discovery Market, 2016 – 2026 (USD Million)
    4. 5.4. Biopharmaceutical Companies
      1. 5.4.1. Global Biopharmaceutical Companies AI for Drug Discovery Market, 2016 – 2026 (USD Million)
    5. 5.5. Academic & Research Institutes
      1. 5.5.1. Global Academic & Research Institutes AI for Drug Discovery Market, 2016 – 2026 (USD Million)
    6. 5.6. Others
      1. 5.6.1. Global Others AI for Drug Discovery Market, 2016 – 2026 (USD Million)
  6. Chapter 6 AI for Drug Discovery Market – Regional Analysis
    1. 6.1. Global AI for Drug Discovery Market Regional Overview
    2. 6.2. Global AI for Drug Discovery Market Share, by Region, 2020 & 2026 (USD Million)
    3. 6.3. North America
      1. 6.3.1. North America AI for Drug Discovery Market, 2016 – 2026 (USD Million)
        1. 6.3.1.1. North America AI for Drug Discovery Market, by Country, 2016 - 2026 (USD Million)
      2. 6.3.2. North America AI for Drug Discovery Market, by Drug Type, 2016 – 2026
        1. 6.3.2.1. North America AI for Drug Discovery Market, by Drug Type, 2016 – 2026 (USD Million)
      3. 6.3.3. North America AI for Drug Discovery Market, by Technology, 2016 – 2026
        1. 6.3.3.1. North America AI for Drug Discovery Market, by Technology, 2016 – 2026 (USD Million)
      4. 6.3.4. North America AI for Drug Discovery Market, by Therapeutic Area, 2016 – 2026
        1. 6.3.4.1. North America AI for Drug Discovery Market, by Therapeutic Area, 2016 – 2026 (USD Million)
      5. 6.3.5. North America AI for Drug Discovery Market, by End User, 2016 – 2026
        1. 6.3.5.1. North America AI for Drug Discovery Market, by End User, 2016 – 2026 (USD Million)
      6. 6.3.6. U.S.
        1. 6.3.6.1. U.S. AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      7. 6.3.7. Canada
        1. 6.3.7.1. Canada AI for Drug Discovery Market, 2016 – 2026 (USD Million)
    4. 6.4. Europe
      1. 6.4.1. Europe AI for Drug Discovery Market, 2016 – 2026 (USD Million)
        1. 6.4.1.1. Europe AI for Drug Discovery Market, by Country, 2016 - 2026 (USD Million)
      2. 6.4.2. Europe AI for Drug Discovery Market, by Drug Type, 2016 – 2026
        1. 6.4.2.1. Europe AI for Drug Discovery Market, by Drug Type, 2016 – 2026 (USD Million)
      3. 6.4.3. Europe AI for Drug Discovery Market, by Technology, 2016 – 2026
        1. 6.4.3.1. Europe AI for Drug Discovery Market, by Technology, 2016 – 2026 (USD Million)
      4. 6.4.4. Europe AI for Drug Discovery Market, by Therapeutic Area, 2016 – 2026
        1. 6.4.4.1. Europe AI for Drug Discovery Market, by Therapeutic Area, 2016 – 2026 (USD Million)
      5. 6.4.5. Europe AI for Drug Discovery Market, by End User, 2016 – 2026
        1. 6.4.5.1. Europe AI for Drug Discovery Market, by End User, 2016 – 2026 (USD Million)
      6. 6.4.6. Germany
        1. 6.4.6.1. Germany AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      7. 6.4.7. France
        1. 6.4.7.1. France AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      8. 6.4.8. U.K.
        1. 6.4.8.1. U.K. AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      9. 6.4.9. Italy
        1. 6.4.9.1. Italy AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      10. 6.4.10. Spain
        1. 6.4.10.1. Spain AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      11. 6.4.11. Rest of Europe
        1. 6.4.11.1. Rest of Europe AI for Drug Discovery Market, 2016 – 2026 (USD Million)
    5. 6.5. Asia Pacific
      1. 6.5.1. Asia Pacific AI for Drug Discovery Market, 2016 – 2026 (USD Million)
        1. 6.5.1.1. Asia Pacific AI for Drug Discovery Market, by Country, 2016 - 2026 (USD Million)
      2. 6.5.2. Asia Pacific AI for Drug Discovery Market, by Drug Type, 2016 – 2026
        1. 6.5.2.1. Asia Pacific AI for Drug Discovery Market, by Drug Type, 2016 – 2026 (USD Million)
      3. 6.5.3. Asia Pacific AI for Drug Discovery Market, by Technology, 2016 – 2026
        1. 6.5.3.1. Asia Pacific AI for Drug Discovery Market, by Technology, 2016 – 2026 (USD Million)
      4. 6.5.4. Asia Pacific AI for Drug Discovery Market, by Therapeutic Area, 2016 – 2026
        1. 6.5.4.1. Asia Pacific AI for Drug Discovery Market, by Therapeutic Area, 2016 – 2026 (USD Million)
      5. 6.5.5. Asia Pacific AI for Drug Discovery Market, by End User, 2016 – 2026
        1. 6.5.5.1. Asia Pacific AI for Drug Discovery Market, by End User, 2016 – 2026 (USD Million)
      6. 6.5.6. China
        1. 6.5.6.1. China AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      7. 6.5.7. Japan
        1. 6.5.7.1. Japan AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      8. 6.5.8. India
        1. 6.5.8.1. India AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      9. 6.5.9. South Korea
        1. 6.5.9.1. South Korea AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      10. 6.5.10. South-East Asia
        1. 6.5.10.1. South-East Asia AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      11. 6.5.11. Rest of Asia Pacific
        1. 6.5.11.1. Rest of Asia Pacific AI for Drug Discovery Market, 2016 – 2026 (USD Million)
    6. 6.6. Latin America
      1. 6.6.1. Latin America AI for Drug Discovery Market, 2016 – 2026 (USD Million)
        1. 6.6.1.1. Latin America AI for Drug Discovery Market, by Country, 2016 - 2026 (USD Million)
      2. 6.6.2. Latin America AI for Drug Discovery Market, by Drug Type, 2016 – 2026
        1. 6.6.2.1. Latin America AI for Drug Discovery Market, by Drug Type, 2016 – 2026 (USD Million)
      3. 6.6.3. Latin America AI for Drug Discovery Market, by Technology, 2016 – 2026
        1. 6.6.3.1. Latin America AI for Drug Discovery Market, by Technology, 2016 – 2026 (USD Million)
      4. 6.6.4. Latin America AI for Drug Discovery Market, by Therapeutic Area, 2016 – 2026
        1. 6.6.4.1. Latin America AI for Drug Discovery Market, by Therapeutic Area, 2016 – 2026 (USD Million)
      5. 6.6.5. Latin America AI for Drug Discovery Market, by End User, 2016 – 2026
        1. 6.6.5.1. Latin America AI for Drug Discovery Market, by End User, 2016 – 2026 (USD Million)
      6. 6.6.6. Brazil
        1. 6.6.6.1. Brazil AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      7. 6.6.7. Mexico
        1. 6.6.7.1. Mexico AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      8. 6.6.8. Rest of Latin America
        1. 6.6.8.1. Rest of Latin America AI for Drug Discovery Market, 2016 – 2026 (USD Million)
    7. 6.7. Middle-East and Africa
      1. 6.7.1. Middle-East and Africa AI for Drug Discovery Market, 2016 – 2026 (USD Million)
        1. 6.7.1.1. Middle-East and Africa AI for Drug Discovery Market, by Country, 2016 - 2026 (USD Million)
      2. 6.7.2. Middle-East and Africa AI for Drug Discovery Market, by Drug Type, 2016 – 2026
        1. 6.7.2.1. Middle-East and Africa AI for Drug Discovery Market, by Drug Type, 2016 – 2026 (USD Million)
      3. 6.7.3. Middle-East and Africa AI for Drug Discovery Market, by Technology, 2016 – 2026
        1. 6.7.3.1. Middle-East and Africa AI for Drug Discovery Market, by Technology, 2016 – 2026 (USD Million)
      4. 6.7.4. Middle-East and Africa AI for Drug Discovery Market, by Therapeutic Area, 2016 – 2026
        1. 6.7.4.1. Middle-East and Africa AI for Drug Discovery Market, by Therapeutic Area, 2016 – 2026 (USD Million)
      5. 6.7.5. Middle-East and Africa AI for Drug Discovery Market, by End User, 2016 – 2026
        1. 6.7.5.1. Middle-East and Africa AI for Drug Discovery Market, by End User, 2016 – 2026 (USD Million)
      6. 6.7.6. GCC Countries
        1. 6.7.6.1. GCC Countries AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      7. 6.7.7. South Africa
        1. 6.7.7.1. South Africa AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      8. 6.7.8. Rest of Middle-East Africa
        1. 6.7.8.1. Rest of Middle-East Africa AI for Drug Discovery Market, 2016 – 2026 (USD Million)
  7. Chapter 7 AI for Drug Discovery Market – Competitive Landscape
    1. 7.1. Competitor Market Share – Revenue
    2. 7.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 7.3. Strategic Developments
      1. 7.3.1. Acquisitions and Mergers
      2. 7.3.2. New Products
      3. 7.3.3. Research & Development Activities
  8. Chapter 8 Company Profiles
    1. 8.1. NVIDIA Corporation
      1. 8.1.1. Company Overview
      2. 8.1.2. Product/Service Portfolio
      3. 8.1.3. NVIDIA Corporation Sales, Revenue, and Gross Margin
      4. 8.1.4. NVIDIA Corporation Revenue and Growth Rate
      5. 8.1.5. NVIDIA Corporation Market Share
      6. 8.1.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    2. 8.2. IBM Watson
      1. 8.2.1. Company Overview
      2. 8.2.2. Product/Service Portfolio
      3. 8.2.3. IBM Watson Sales, Revenue, and Gross Margin
      4. 8.2.4. IBM Watson Revenue and Growth Rate
      5. 8.2.5. IBM Watson Market Share
      6. 8.2.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    3. 8.3. Google
      1. 8.3.1. Company Overview
      2. 8.3.2. Product/Service Portfolio
      3. 8.3.3. Google Sales, Revenue, and Gross Margin
      4. 8.3.4. Google Revenue and Growth Rate
      5. 8.3.5. Google Market Share
      6. 8.3.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    4. 8.4. Atomwise, Inc.
      1. 8.4.1. Company Overview
      2. 8.4.2. Product/Service Portfolio
      3. 8.4.3. Atomwise, Inc. Sales, Revenue, and Gross Margin
      4. 8.4.4. Atomwise, Inc. Revenue and Growth Rate
      5. 8.4.5. Atomwise, Inc. Market Share
      6. 8.4.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    5. 8.5. Deep Genomics
      1. 8.5.1. Company Overview
      2. 8.5.2. Product/Service Portfolio
      3. 8.5.3. Deep Genomics Sales, Revenue, and Gross Margin
      4. 8.5.4. Deep Genomics Revenue and Growth Rate
      5. 8.5.5. Deep Genomics Market Share
      6. 8.5.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    6. 8.6. Cloud Pharmaceuticals, Inc.
      1. 8.6.1. Company Overview
      2. 8.6.2. Product/Service Portfolio
      3. 8.6.3. Cloud Pharmaceuticals, Inc. Sales, Revenue, and Gross Margin
      4. 8.6.4. Cloud Pharmaceuticals, Inc. Revenue and Growth Rate
      5. 8.6.5. Cloud Pharmaceuticals, Inc. Market Share
      6. 8.6.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    7. 8.7. Xtalpi, Inc.
      1. 8.7.1. Company Overview
      2. 8.7.2. Product/Service Portfolio
      3. 8.7.3. Xtalpi, Inc. Sales, Revenue, and Gross Margin
      4. 8.7.4. Xtalpi, Inc. Revenue and Growth Rate
      5. 8.7.5. Xtalpi, Inc. Market Share
      6. 8.7.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    8. 8.8. Verge Genomics
      1. 8.8.1. Company Overview
      2. 8.8.2. Product/Service Portfolio
      3. 8.8.3. Verge Genomics Sales, Revenue, and Gross Margin
      4. 8.8.4. Verge Genomics Revenue and Growth Rate
      5. 8.8.5. Verge Genomics Market Share
      6. 8.8.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    9. 8.9. Insilico Medicine
      1. 8.9.1. Company Overview
      2. 8.9.2. Product/Service Portfolio
      3. 8.9.3. Insilico Medicine Sales, Revenue, and Gross Margin
      4. 8.9.4. Insilico Medicine Revenue and Growth Rate
      5. 8.9.5. Insilico Medicine Market Share
      6. 8.9.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    10. 8.10. Benevolent AI
      1. 8.10.1. Company Overview
      2. 8.10.2. Product/Service Portfolio
      3. 8.10.3. Benevolent AI Sales, Revenue, and Gross Margin
      4. 8.10.4. Benevolent AI Revenue and Growth Rate
      5. 8.10.5. Benevolent AI Market Share
      6. 8.10.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    11. 8.11. Microsoft Corporation
      1. 8.11.1. Company Overview
      2. 8.11.2. Product/Service Portfolio
      3. 8.11.3. Microsoft Corporation Sales, Revenue, and Gross Margin
      4. 8.11.4. Microsoft Corporation Revenue and Growth Rate
      5. 8.11.5. Microsoft Corporation Market Share
      6. 8.11.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    12. 8.12. Exscientia
      1. 8.12.1. Company Overview
      2. 8.12.2. Product/Service Portfolio
      3. 8.12.3. Exscientia Sales, Revenue, and Gross Margin
      4. 8.12.4. Exscientia Revenue and Growth Rate
      5. 8.12.5. Exscientia Market Share
      6. 8.12.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    13. 8.13. Owkin, Inc.
      1. 8.13.1. Company Overview
      2. 8.13.2. Product/Service Portfolio
      3. 8.13.3. Owkin, Inc. Sales, Revenue, and Gross Margin
      4. 8.13.4. Owkin, Inc. Revenue and Growth Rate
      5. 8.13.5. Owkin, Inc. Market Share
      6. 8.13.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    14. 8.14. Berg LLC,
      1. 8.14.1. Company Overview
      2. 8.14.2. Product/Service Portfolio
      3. 8.14.3. Berg LLC, Sales, Revenue, and Gross Margin
      4. 8.14.4. Berg LLC, Revenue and Growth Rate
      5. 8.14.5. Berg LLC, Market Share
      6. 8.14.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    15. 8.15. Cyclica
      1. 8.15.1. Company Overview
      2. 8.15.2. Product/Service Portfolio
      3. 8.15.3. Cyclica Sales, Revenue, and Gross Margin
      4. 8.15.4. Cyclica Revenue and Growth Rate
      5. 8.15.5. Cyclica Market Share
      6. 8.15.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    16. 8.16. Numerate
      1. 8.16.1. Company Overview
      2. 8.16.2. Product/Service Portfolio
      3. 8.16.3. Numerate Sales, Revenue, and Gross Margin
      4. 8.16.4. Numerate Revenue and Growth Rate
      5. 8.16.5. Numerate Market Share
      6. 8.16.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    17. 8.17. Numedii, Inc.
      1. 8.17.1. Company Overview
      2. 8.17.2. Product/Service Portfolio
      3. 8.17.3. Numedii, Inc. Sales, Revenue, and Gross Margin
      4. 8.17.4. Numedii, Inc. Revenue and Growth Rate
      5. 8.17.5. Numedii, Inc. Market Share
      6. 8.17.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    18. 8.18. Envisagenics
      1. 8.18.1. Company Overview
      2. 8.18.2. Product/Service Portfolio
      3. 8.18.3. Envisagenics Sales, Revenue, and Gross Margin
      4. 8.18.4. Envisagenics Revenue and Growth Rate
      5. 8.18.5. Envisagenics Market Share
      6. 8.18.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    19. 8.19. Twoxar, Incorporated
      1. 8.19.1. Company Overview
      2. 8.19.2. Product/Service Portfolio
      3. 8.19.3. Twoxar, Incorporated Sales, Revenue, and Gross Margin
      4. 8.19.4. Twoxar, Incorporated Revenue and Growth Rate
      5. 8.19.5. Twoxar, Incorporated Market Share
      6. 8.19.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    20. 8.20. GNS Healthcare
      1. 8.20.1. Company Overview
      2. 8.20.2. Product/Service Portfolio
      3. 8.20.3. GNS Healthcare Sales, Revenue, and Gross Margin
      4. 8.20.4. GNS Healthcare Revenue and Growth Rate
      5. 8.20.5. GNS Healthcare Market Share
      6. 8.20.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    21. 8.21. BioSymetrics
      1. 8.21.1. Company Overview
      2. 8.21.2. Product/Service Portfolio
      3. 8.21.3. BioSymetrics Sales, Revenue, and Gross Margin
      4. 8.21.4. BioSymetrics Revenue and Growth Rate
      5. 8.21.5. BioSymetrics Market Share
      6. 8.21.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    22. 8.22. Euretos
      1. 8.22.1. Company Overview
      2. 8.22.2. Product/Service Portfolio
      3. 8.22.3. Euretos Sales, Revenue, and Gross Margin
      4. 8.22.4. Euretos Revenue and Growth Rate
      5. 8.22.5. Euretos Market Share
      6. 8.22.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
  9. Chapter 9 AI for Drug Discovery — Industry Analysis
    1. 9.1. Introduction and Taxonomy
    2. 9.2. AI for Drug Discovery Market – Key Trends
      1. 9.2.1. Market Drivers
      2. 9.2.2. Market Restraints
      3. 9.2.3. Market Opportunities
    3. 9.3. Value Chain Analysis
    4. 9.4. Key Mandates and Regulations
    5. 9.5. Technology Roadmap and Timeline
    6. 9.6. AI for Drug Discovery Market – Attractiveness Analysis
      1. 9.6.1. By Drug Type
      2. 9.6.2. By Technology
      3. 9.6.3. By Therapeutic Area
      4. 9.6.4. By End User
      5. 9.6.5. By Region
  10. Chapter 10 Report Conclusion & Key Insights
    1. 10.1. Key Insights from Primary Interviews & Surveys Respondents
    2. 10.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  11. Chapter 11 Research Approach & Methodology
    1. 11.1. Report Description
    2. 11.2. Research Scope
    3. 11.3. Research Methodology
      1. 11.3.1. Secondary Research
      2. 11.3.2. Primary Research
      3. 11.3.3. Statistical Models
        1. 11.3.3.1. Company Share Analysis Model
        2. 11.3.3.2. Revenue Based Modeling
      4. 11.3.4. Research Limitations

      List of Figures

      Fig.1	Product Picture of AI for Drug Discovery
      Fig.2	Global AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.3	Global AI for Drug Discovery Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
      Fig.4	Global AI for Drug Discovery Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
      Fig.5	COVID-19 Impacts on AI for Drug Discovery Market
      Fig.6	COVID-19 Impact on the Players
      Fig.7	Business Strategies and Recommendations
      Fig.8	Global AI for Drug Discovery Market Share, by Drug Type, 2020 & 2026 (USD Million)
      Fig.9	Global Small Molecule AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.10	Global Large Molecule AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.11	Global AI for Drug Discovery Market Share, by Technology, 2020 & 2026 (USD Million)
      Fig.12	Global Machine Learning AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.13	Global Others Technologies AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.14	Global AI for Drug Discovery Market Share, by Therapeutic Area, 2020 & 2026 (USD Million)
      Fig.15	Global Metabolic Diseases AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.16	Global Cardiovascular Diseases AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.17	Global Immuno-Oncology AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.18	Global Oncology AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.19	Global Neurodegenerative Diseases AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.20	Global Others AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.21	Global AI for Drug Discovery Market Share, by End User, 2020 & 2026 (USD Million)
      Fig.22	Global Pharmaceutical Companies AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.23	Global Biopharmaceutical Companies AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.24	Global Academic & Research Institutes AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.25	Global Others AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.26	Global AI for Drug Discovery Market Share, by Region, 2020 & 2026 (USD Million)
      Fig.27	North America AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.28	U.S. AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.29	Canada AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.30	Europe AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.31	Germany AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.32	France AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.33	U.K. AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.34	Italy AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.35	Spain AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.36	Rest of Europe AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.37	Asia Pacific AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.38	China AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.39	Japan AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.40	India AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.41	South  Korea AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.42	South-East Asia AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.43	Rest of Asia Pacific AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.44	Latin America AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.45	Brazil AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.46	Mexico AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.47	Rest of Latin America AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.48	Middle-East and Africa AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.49	GCC Countries AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.50	South Africa AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.51	Rest of Middle-East Africa AI for Drug Discovery Market, 2016 – 2026 (USD Million)
      Fig.52	Competitor Market Share – Revenue
      Fig.53	NVIDIA Corporation Revenue and Growth Rate
      Fig.54	NVIDIA Corporation Market Share
      Fig.55	IBM Watson Revenue and Growth Rate
      Fig.56	IBM Watson Market Share
      Fig.57	Google Revenue and Growth Rate
      Fig.58	Google Market Share
      Fig.59	Atomwise, Inc. Revenue and Growth Rate
      Fig.60	Atomwise, Inc. Market Share
      Fig.61	Deep Genomics Revenue and Growth Rate
      Fig.62	Deep Genomics Market Share
      Fig.63	Cloud Pharmaceuticals, Inc. Revenue and Growth Rate
      Fig.64	Cloud Pharmaceuticals, Inc. Market Share
      Fig.65	Xtalpi, Inc. Revenue and Growth Rate
      Fig.66	Xtalpi, Inc. Market Share
      Fig.67	Verge Genomics Revenue and Growth Rate
      Fig.68	Verge Genomics Market Share
      Fig.69	Insilico Medicine Revenue and Growth Rate
      Fig.70	Insilico Medicine Market Share
      Fig.71	Benevolent AI Revenue and Growth Rate
      Fig.72	Benevolent AI Market Share
      Fig.73	Microsoft Corporation Revenue and Growth Rate
      Fig.74	Microsoft Corporation Market Share
      Fig.75	Exscientia Revenue and Growth Rate
      Fig.76	Exscientia Market Share
      Fig.77	Owkin, Inc. Revenue and Growth Rate
      Fig.78	Owkin, Inc. Market Share
      Fig.79	Berg LLC, Revenue and Growth Rate
      Fig.80	Berg LLC, Market Share
      Fig.81	Cyclica Revenue and Growth Rate
      Fig.82	Cyclica Market Share
      Fig.83	Numerate Revenue and Growth Rate
      Fig.84	Numerate Market Share
      Fig.85	Numedii, Inc. Revenue and Growth Rate
      Fig.86	Numedii, Inc. Market Share
      Fig.87	Envisagenics Revenue and Growth Rate
      Fig.88	Envisagenics Market Share
      Fig.89	Twoxar, Incorporated Revenue and Growth Rate
      Fig.90	Twoxar, Incorporated Market Share
      Fig.91	GNS Healthcare Revenue and Growth Rate
      Fig.92	GNS Healthcare Market Share
      Fig.93	BioSymetrics Revenue and Growth Rate
      Fig.94	BioSymetrics Market Share
      Fig.95	Euretos Revenue and Growth Rate
      Fig.96	Euretos Market Share
      Fig.97	Market Dynamics
      Fig.98	Global AI for Drug Discovery – Value Chain Analysis
      Fig.99	Key Mandates and Regulations
      Fig.100	Technology Roadmap and Timeline
      Fig.101	Market Attractiveness Analysis – By Drug Type
      Fig.102	Market Attractiveness Analysis – By Technology
      Fig.103	Market Attractiveness Analysis – By Therapeutic Area
      Fig.104	Market Attractiveness Analysis – By End User
      Fig.105	Market Attractiveness Analysis – By Region
      

      List of Tables

      Table 1	Global AI for Drug Discovery Market, 2020 & 2026 (USD Million)
      Table 2	Global AI for Drug Discovery Market, by Drug Type, 2016 – 2026 (USD Million)
      Table 3	Global AI for Drug Discovery Market, by Technology, 2016 – 2026 (USD Million)
      Table 4	Global AI for Drug Discovery Market, by Therapeutic Area, 2016 – 2026 (USD Million)
      Table 5	Global AI for Drug Discovery Market, by End User, 2016 – 2026 (USD Million)
      Table 6	Global AI for Drug Discovery Market, by Region, 2016 – 2026 (USD Million)
      Table 7	North America AI for Drug Discovery Market, by Country, 2016 – 2026 (USD Million)
      Table 8	North America AI for Drug Discovery Market, by Drug Type, 2016 – 2026 (USD Million)
      Table 9 North America AI for Drug Discovery Market, by Technology, 2016 – 2026 (USD Million)
      Table 10 North America AI for Drug Discovery Market, by Therapeutic Area, 2016 – 2026 (USD Million)
      Table 11 North America AI for Drug Discovery Market, by End User, 2016 – 2026 (USD Million)
      Table 12 Europe AI for Drug Discovery Market, by Country, 2016 – 2026 (USD Million)
      Table 13 Europe AI for Drug Discovery Market, by Drug Type, 2016 – 2026 (USD Million)
      Table 14 Europe AI for Drug Discovery Market, by Technology, 2016 – 2026 (USD Million)
      Table 15 Europe AI for Drug Discovery Market, by Therapeutic Area, 2016 – 2026 (USD Million)
      Table 16 Europe AI for Drug Discovery Market, by End User, 2016 – 2026 (USD Million)
      Table 17 Asia Pacific AI for Drug Discovery Market, by Country, 2016 – 2026 (USD Million)
      Table 18 Asia Pacific AI for Drug Discovery Market, by Drug Type, 2016 – 2026 (USD Million)
      Table 19 Asia Pacific AI for Drug Discovery Market, by Technology, 2016 – 2026 (USD Million)
      Table 20 Asia Pacific AI for Drug Discovery Market, by Therapeutic Area, 2016 – 2026 (USD Million)
      Table 21 Asia Pacific AI for Drug Discovery Market, by End User, 2016 – 2026 (USD Million)
      Table 22 Latin America AI for Drug Discovery Market, by Country, 2016 – 2026 (USD Million)
      Table 23 Latin America AI for Drug Discovery Market, by Drug Type, 2016 – 2026 (USD Million)
      Table 24 Latin America AI for Drug Discovery Market, by Technology, 2016 – 2026 (USD Million)
      Table 25 Latin America AI for Drug Discovery Market, by Therapeutic Area, 2016 – 2026 (USD Million)
      Table 26 Latin America AI for Drug Discovery Market, by End User, 2016 – 2026 (USD Million)
      Table 27 Middle-East and Africa AI for Drug Discovery Market, by Country, 2016 – 2026 (USD Million)
      Table 28 Middle-East and Africa AI for Drug Discovery Market, by Drug Type, 2016 – 2026 (USD Million)
      Table 29 Middle-East and Africa AI for Drug Discovery Market, by Technology, 2016 – 2026 (USD Million)
      Table 30 Middle-East and Africa AI for Drug Discovery Market, by Therapeutic Area, 2016 – 2026 (USD Million)
      Table 31 Middle-East and Africa AI for Drug Discovery Market, by End User, 2016 – 2026 (USD Million)
      Table 32 Global AI for Drug Discovery Market - Company Revenue Analysis, 2016 – 2020 (USD Million)
      Table 33 Global AI for Drug Discovery Market - Company Revenue Share Analysis, 2016 – 2020 (%)
      Table 34 Acquisitions and Mergers
      Table 35 Market Drivers – Impact Analysis
      Table 36 Market Restraints
      Table 37 Market Opportunities
      

Industry Major Market Players

  •  Recursion Pharmaceuticals,
  •  AstraZeneca,
  •  Astrocyte Pharmaceuticals Inc.,
  •  NeuroVive Pharmaceutical AB,
  •  twoXAR  Incorporated,
  •  Biogen,
  •  Bionure Farma,
  •  S.L.,
  •  BIOAGE,
  •  Genervon Biopharmaceuticals,
  •  LLC.,
  •  Hoffmann-La Roche Ltd.,
  •  Neuren Pharmaceuticals,
  •  Atomwise,
  •  Insilico Medicine,
  •  Silicon Therapeutics,
  •  Cloud Pharmaceuticals Inc.,
  •  Novartis Pharmaceuticals Corporation,
  •  Teva Pharmaceutical Industries Ltd.,
  •  BenevolentAI,
  •  Exscientia,
  •  Numerate,
  •  Envisagenics Inc.,
  •  Accutar Biotech.

Frequently Asked Questions

Strict enforcement of laws by government authorities mandating AI in Drug Discovery Market.
According to Facts and Factors research report, the global AI in Drug Discovery Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new AI in Drug Discovery Market will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for AI in Drug Discovery Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of AI in Drug Discovery Market in North America over coming decade.
key questions and why choose us

Related Reports

report img

Corporate Wellness Market

[205+ Pages Report] According to a Facts and Factors market research report, the globalcorporate wellness solutions market is projected to reach USD 100 Billion by 2026 from USD 61.3 Billion in 2020, at a CAGR of 8.5% during the forecast period. Global Corporate Wellness Market: Overview Corpo...

Published Date : 27-Sep-2021 | | Category : | Pages : 205 | Format : Read more

Inquiry for Buying Request Sample
report img

Medical Polymers Market

[203+ Pages Report] According to a survey released by Facts and Factors, the globalmedical polymers market was valued at USD 16,500 Million in 2020 and is predicted to reach USD 28,290 Million by the end of 2026, rising at a CAGR of nearly 9.40% between 2021 and 2026. Global Medical Polymers Mar...

Published Date : 08-Sep-2021 | | Category : | Pages : 203 | Format : Read more

Inquiry for Buying Request Sample